Study: Protein disruption linked to blood cancers

10/15/2008 | United Press International

A study by Stanford University School of Medicine researchers is the first to directly associate the retinoblastoma family of proteins to blood and immune cell production. Interrupting the function of the molecules leads to a proliferation of certain cells, similar to those that occur in several human blood cancers.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ